Trial Profile
Clinical Study of A Single-Center Clinical Study to Evaluate the Safety and Biodistribution of Technetium Tc 99m Ec20 in Normal Volunteers and Ovarian Cancer Patients.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Technetium Tc99m etarfolatide (Primary)
- Indications Ovarian cancer
- Focus Pharmacokinetics
- Sponsors Endocyte
- 27 Apr 2015 New trial record